Phenotypic diversity and drug susceptibility of Trypanosoma cruzi TcV clinical isolates
Trypanosoma cruzi is a genetically heterogeneous group of organisms that cause Chagas disease. It has been long suspected that the clinical outcome of the disease and response to therapeutic agents are, at least in part, related to the genetic characteristics of the parasite. Herein, we sought to va...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , , |
| Format: | article |
| Language: | English |
| Published: |
2018
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/20.500.12008/22741 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Phenotypic diversity and drug susceptibility of Trypanosoma cruzi TcV clinical isolates
- Comparative repeatome analysis on Triatoma infestans Andean and Non-Andean lineages, main vector of Chagas disease
- High‑throughput analysis of the Trypanosoma cruzi minicirculome (mcDNA) unveils structural variation and functional diversity
- Trypanosoma cruzi Isolates Naturally Adapted to Congenital Transmission Display a Unique Strategy of Transplacental Passage
- Paracrine signaling mediated by the cytosolic tryparedoxin peroxidase of Trypanosoma cruzi
- Trypanosoma cruzi Isolates Naturally Adapted to Congenital Transmission Display a Unique Strategy of Transplacental Passage
- Deep serological profiling of the Trypanosoma cruzi TSSA antigen reveals different epitopes and modes of recognition by Chagas disease patients